Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
7.43
-0.33 (-4.25%)
At close: Apr 1, 2025, 4:00 PM
7.90
+0.47 (6.38%)
After-hours: Apr 1, 2025, 4:12 PM EDT
Forte Biosciences Employees
Forte Biosciences had 9 employees as of December 31, 2023. The number of employees increased by 3 or 50.00% compared to the previous year.
Employees
9
Change (1Y)
3
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$3,942,000
Market Cap
47.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | 3 | 50.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | 5 | -4 | -44.44% |
| Dec 31, 2020 | 9 | 8 | 800.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FBRX News
- 1 day ago - Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Business Wire
- 2 months ago - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - Business Wire
- 4 months ago - Forte Biosciences to Host R&D Day December 3, 2024 - Business Wire
- 4 months ago - Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - Business Wire
- 4 months ago - Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update - Business Wire
- 8 months ago - Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update - Business Wire
- 11 months ago - Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - Business Wire
- 11 months ago - Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update - Business Wire